Amazon’s new healthcare approach mines medical records

Amy Baxter | | Health Exec | Digital Transformation

Amazon is now selling software that “mines” medical records of patients to find ways to improve care and lower costs for providers, according to a report from The Wall Street Journal.

Amazon has several other forays into the healthcare space, including a joint venture with Berkshire Hathaway and JPMorgan Chase to create a new entity that focuses on improving healthcare for employees of the three companies.

The latest move takes aim at a market worth more than $7 billion a year, to store and analyze health information, according to the report. The software reads digitized patient records using deep learning to find specific data points.

Demand for this capability is likely to increase.

See the full story below:

Big Tech Expands Footprint in Health

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

4 points crucial to the nimble regulation of GenAI
5 tips to learn AI from scratch and for free
Good AI governance can spell the difference between smashing success and mere learning experience
10 ways AI, robotics are improving pediatric care in real-world settings
Partnership on AI valiantly trying to wrap arms around the world
How the FDA sees its role vis-à-vis AI in healthcare

Around the web

AI in Healthcare
4 points crucial to the nimble regulation of GenAI

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Design by Adaptive Theme
Trimed Popup
Trimed Popup